China Sky One Medical, Inc. CFO to Present at Roth Conference
Inc. (“China Sky One Medical” or “the Company”) (Nasdaq: CSKI), a leading
fully integrated pharmaceutical company producing over-the-counter drugs in
Chief Financial Officer, Mr. Yu-bo (
one-on-one meetings at the upcoming Roth 21st Annual OC Growth Stock
Conference in
The date and time of China Sky One Medical's presentation are as follows:
Date: Tuesday, February 17, 2009
Time: 3:00 p.m. Pacific Time
Venue: Track 5
The Ritz Carlton Laguna Niguel
One Ritz-Carlton Drive
Dana Point, California 92629
Webcast: http://www.wsw.com/webcast/roth20/cski/
A replay of the presentation will be available for 90 days following the
live presentation using the same link and will also be available on the
Company’s website.
The ROTH 21st Annual OC Growth Stock Conference will feature presentations
from over 200 growth companies. This event is designed to provide investors
with a unique opportunity to gain insight into leading companies across all
sectors. Additionally, there will be a special track dedicated to companies
based in
operations, and speakers will spend the majority of their time discussing
topics that will highlight the value and investment opportunity their company
represents.
Interested parties and investors may find more information about the
conference by contacting conference@roth.com or calling (800) 933-6830.
About China Sky One Medical, Inc.
China Sky One Medical, Inc., a
The Company engages in the manufacturing, marketing and distribution of
pharmaceutical, medicinal and diagnostic products. Through its wholly-owned
subsidiaries, Harbin Tian Di Ren Medical Science and Technology Company
(“TDR”),
Tianlong Pharmaceutical, Inc. (“Tianlong”) and Peng Lai Jin Chuang
Pharmaceutical Company (“Jin Chuang”) the Company manufactures and distributes
over-the-counter pharmaceutical products, which make up its major revenue
source. For more information, visit http://www.skyonemedical.com .
Safe Harbor Statement
Certain of the statements made in the press release constitute
forward-looking statements within the meaning of the Private Securities
Litigation Reform Act of 1995. These statements can be identified by the use
of forward- looking terminology such as “believe,” “expect,” “may,” “will,”
“should,” “project,” “plan,” “seek,” “intend,” or “anticipate” or the negative
thereof or comparable terminology. Such statements typically involve risks and
uncertainties and may include financial projections or information regarding
our future plans, objectives or performance. Actual results could differ
materially from the expectations reflected in such forward-looking statements
as a result of a variety of factors, including the risks associated with the
effect of changing economic conditions in
variations in cash flow, reliance on collaborative retail partners and on new
product development, variations in new product development, risks associated
with rapid technological change, and the potential of introduced or undetected
flaws and defects in products, and other risk factors detailed in reports
filed with the Securities and Exchange Commission from time to time.
For more information, please contact:
Company Contact:
China Sky One Medical, Inc.
Mr. Yu-Bo (Stanley) Hao, CFO
Tel: +86-451-5399-4069
Email: china_sky_one@yahoo.cn
Investor Relations Contact:
CCG Investor Relations
Mr. Crocker Coulson, President
Tel: +1-646-213-1915
Email: crocker.coulson@ccgir.com
Website: http://www.ccgirasia.com
SOURCE China Sky One Medical, Inc.